Four years' treatment with ketamine and a trial of dextromethol-phan in a patient with severe post-herpetic neuralgia

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 3, 1997, Pages 422-426

  Klepstad, P ^a,b   Borchgrevink, P C ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Dextromethorphan; Ketamine; Neuropathic pain; NMDA receptors; Postherpetic pain

Indexed keywords

ACICLOVIR; DEXTROMETHORPHAN; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO;

AGED; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CASE REPORT; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HERPES ZOSTER; HUMAN; MALE; ORAL DRUG ADMINISTRATION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL;

EID: 0030996310     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04709.x     Document Type: Article

References (15)

1. Klepstad P, Maurset A, Moberg ER, Øye I. Evidence of a role for NMDA receptors in pain perception. Eur J Pharmacol 1990: 187: 513-518.
2. Maurset A, Øye I. Ketamine: klinisk nyttig - farmakologisk interessant. Nord Med 1990: 105: 182-183.
3. Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991: 44: 293-299.
4. Dickinson AH. A cure for wind-up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990: 11: 307-309.
5. Yaksh TL. Behavioral and autonomic correlates of tactile evoked allodynia deduced by spinal glycine inhibition: effects of the modulatory receptors systems and excitatory amino acid antagonists. Pain 1989: 37: 111-123.
6. Kristensen JD, Svensson B, Gordh Jr. T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992: 51: 249-253.
7. Eide PK, Stubhaug A, Øye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995: 61: 221-228.
8. Mathisen LC, Skjelbred P, Skoglund LA, Øye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic pain. Pain 1995: 61: 215-220.
9. Stannard CF, Porter GE. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 1993: 54: 227-230.
10. Mercandanta S, Lodi F, Sapio M, Calligara M, Serretta R. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage 1995: 10: 564-568.
11. Price D, Mao J, Frenk H, Mayer DJ. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of pain in man. Pain 1994: 59: 165-174.
12. McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integrated n-of-1 design. Pain 1994: 59: 127-133.
13. Borchgrevink PC, Klepstad P, Thompson EN. Ketamine as daily low i.m. and p.o. doses has dramatically reduced a severe case of post-herpetic neuralgia for 5 months. Abstract 512, IASP 7th World Congress on pain. Paris. 1993.
14. Persson J, Axelsson G, Hallin RG, Gustafsson LL. Beneficial effects of ketamine in a chronic pain state with allodynia, possible due to central sensitization. Pain 1995: 60: 217-222.
15. + channels. Eur J Pharmacol 1989: 163: 327-335.